Delic Labs Applies For Dealer's License To Work With MDMA And LSD For Medical Purposes

Psychedelic wellness platform Delic Holding Corp Inc. (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) said Wednesday that Delic Labs has applied for a Health 56 Exemption that would allow the scientists to perform research and tests on a host of compounds outside of psychedelic mushrooms, including MDMA and LSD.

The move follows the company's recent announcement that it's merging with Ketamine Wellness Centers Arizona LLC in a $10 million deal and partnership with Paradigm Healthcare to bring state-of-the-art testing to Ketamine Infusion Centers LLC.

Currently, the lab holds a 56 Exemption for chemistry …

Full story available on Benzinga.com

More Delic Labs Applies For Dealer's License To Work With MDMA And LSD For Medical Purposes